In the present study, by incorporating data from a public databases and our tumor center, we found that ASF1B expression was higher in tumor tissue compared to paracancerous normal tissues and that the high expression of ASF1B predicted poor outcome in HCC patients. The gene discussed is ASF1B; the disease is neoplasm.